Navamedic AB

Neurology

Navamedic AB is involved in clinical research centered on Parkinson’s disease, with a focus on patient-facing support tools linked to treatment use and daily disease management.

  • Parkinson’s disease
  • Neurological care
  • Movement disorder management

The sponsor’s research activity reflects interest in practical treatment support within neurology, particularly solutions that affect how patients interact with their medication in routine care.

Medication Delivery and Adherence Support

Its clinical trial activity includes evaluation of a medicine dispenser and companion app, indicating a therapeutic interest in improving medication handling and patient use of prescribed therapies.

  • Medicine dispensing devices
  • Digital medication support
  • Treatment adherence

This area highlights care pathways where device-assisted therapy may support more structured medicine administration for people living with chronic neurological disease.

Digital Health Tools

Navamedic AB also shows interest in app-based patient support, linking medication use with digital tools that can assist patients in managing their therapy experience.

  • Patient apps
  • Connected treatment support
  • Self-management tools

The research landscape includes digital therapeutics adjacent to pharmaceutical care, with emphasis on practical tools used alongside prescribed treatment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • An observational study of carbidopa and levodopa use with a new dispensing device and app in patients with Parkinson’s disease

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Sweden